Alzheon Appoints Dennis H Langer MD JD To Board Of Directors
Dr. Langer joins Alzheon's Board of Directors at a time when Alzheon is preparing to begin pivotal Phase 3 studies of ALZ-801 in Alzheimer's disease ...
Related Articles
- Immune Pharma Names Dr. Jeff Paley To Its Board Of Directors also published in biospace.com
- Airbnb Adds Outgoing American Express CEO Kenneth Chenault To Board of Directors also categorized in BoardMoves
- PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves
- Twitter's Jack Dorsey To Join Disney Board Of Directors also categorized in BoardMoves
- Blueprint Medicines (BPMC) Appoints Lynn Seely, MD to Board of Directors also published in biospace.com
- Amazon's Board Diversity Push Could Destroy Traditional Retail also categorized in BoardMoves
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- Honest Company Diversifies Its Leadership With A Second Female Board Member also categorized in BoardMoves
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves
- Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board also categorized in BoardMoves
Login to comment.